 SAN DIEGO , Nov. 2, 2022 PRNewswire -- Aethlon Medical, Inc. Nasdaq: AEMD, a company developing medical therapeutics to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second quarter ended September 30, 2022, at 4:15 p.m. EST on Monday, November 14, 2022. 